Results 161 to 170 of about 20,735 (212)
Third Booster Half Dose of ChAdOx1-nCov-19 Is Effective, Safe, and Induces Long-Duration Humoral and Cellular Immune Response to Omicron: 1-Year Follow-Up of Viana Study. [PDF]
Vaccines (Basel)Medeiros-Junior NF, Gouvea MDPG, Camacho LAB, Villela DAM, Lima SMB, Schwarcz WD, Azevedo AS, Neto LFP, Domingues CMAS, Fantoni RNDS, Forechi L, Ruchdeschel T, Albertino LF, Pereira M, Rizzi RB, Muniz SM, Santos HCD, de Oliveira Roza TL, Oliveira YGP, Dias LH, Miyamoto ST, Tapia KRL, Lyra DGP, Jubini JD, Burian APN, Moulaz IR, Araújo MF, Tort LFL, Oliveira ACA, Oliveira Prado R, Pereira AAS, Miranda VHS, Speziali E, Costa-Pereira C, Alves CC, Carvalho KRA, Dos Santos LM, Oliveira-Carvalho N, Oliveira G, Santos TMAFD, Figueiredo ACC, Costa-Rocha IA, Campi-Azevedo AC, Peruhype-Magalhães V, Garcia CC, Siqueira MM, Antonelli LRDV, Coelho-Dos-Reis JGA, Teixeira-Carvalho A, Mill JG, Martins-Filho OA, Valim V. +51 moreeuropepmc +1 more sourceRetrospective Cohort Analysis of Survival After SARS-CoV-2 Infection by Vaccination Status in Jamaica, April-December 2021. [PDF]
Vaccines (Basel)Webster-Kerr K, Grant A, Harris A, Campbell E, Henningham D, Brown M, Rowe D, Lord C, Thorpe R, Mullings T, Wiggan J, Martin-Chen N, Dawkins-Beharie T, Duncan J. +13 moreeuropepmc +1 more sourceNeutralizing antibody response to different COVID-19 vaccines in Brazil: the impact of previous infection and booster doses. [PDF]
Front ImmunolCaetano BLL, Pinto PBA, Pacheco AR, Lage AR, Pereira ASG, Nascimento AVP, Machado TR, Paulino A, Medeiros TL, Fernandes-Siqueira LO, Da Poian AT, Horbach IS, Azevedo AS, Costa SM, Alves AMB. +14 moreeuropepmc +1 more sourceImmunogenicity and Safety of ChAdOx1 nCoV-19 (AZD1222) as a Homologous Fourth-Dose Booster: A Substudy of the Phase 3 COV003 Trial in Brazil. [PDF]
Mayo Clin Proc Innov Qual OutcomesCosta Clemens SA, Bibi S, Marchevsky NG, Aley PK, Cappuccini F, Davies SA, Gonzalez I, Kelly SC, Mujadidi YF, Pipolo Milan E, Schwarzbold AV, Sprinz E, Voysey M, Weckx LY, Wright D, Bansal H, Bergagård MAS, Isaacs AJ, Kelly EJ, Lan D, Morgan S, Shankar NK, Shoemaker K, Villafana TL, Lambe T, Green JA, Pollard AJ. +26 moreeuropepmc +1 more sourceMAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines. [PDF]
Sci ImmunolAmini A, Garner LC, Shaw RH, Kelly NW, Adele S, Skelly DT, Dejnirattisai W, Greenland M, Liu X, Heslington A, Hackstein CP, Murray SM, Vano CR, Stafford L, Johnson S, Sayaf K, Pudjohartono MF, Clutterbuck EA, PITCH Consortium‡, Com-COV Study Group‡, Bibi S, Conlon CP, James T, Jeffery K, Kronsteiner B, Mentzer AJ, O'Shea D, Ramasamy MN, Screaton GR, Snape MD, Hogan AE, Barnes E, Lambe T, Dunachie SJ, Provine NM, Klenerman P, PITCH Consortium, Com-COV Study Group. +37 moreeuropepmc +1 more sourceNipah virus vaccines evaluated in pigs as a 'One Health' approach to protect public health. [PDF]
NPJ VaccinesMcLean RK, Pedrera M, Thakur N, Elrefaey AME, Hodgson S, Lowther S, Reid T, Todd S, Rowe B, Bergfeld J, Trinidad L, Riddell S, Edwards S, Payne J, Barr J, Rye N, Bruce M, Poole T, Brown S, Dalziel T, Au G, Fisher M, Layton R, Lambe T, Chappell K, Isaacs A, Watterson D, Mourino M, Raue R, Shanta IS, Siddika A, Begum MN, Rahman S, Bhuyan AAM, Alam M, Rahman MZ, Rahman M, Tchilian E, Gilbert SC, Young P, Bailey D, Marsh GA, Graham SP. +42 moreeuropepmc +1 more sourcemRNA prime-boost vaccination promotes clonal continuity in germinal center reactions and broadens SARS-CoV-2 variant coverage. [PDF]
Mol TherCiancaglini M, Fixemer J, Seven C, Dimitrova M, Finozzi D, Weklak D, Kastner AL, Jönsson F, Wagner I, Vincenti I, Peters A, Newby ML, Crispin M, Merkler D, Kreppel F, Pinschewer DD. +15 moreeuropepmc +1 more source
